GENEVA, July 2 -- REVIVA PHARMACEUTICALS, INC. filed a patent application (US2025/059527) for “METHOD FOR TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA”. With publication no. WO/2026/136179, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....